EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Blood pressure can be seriously elevated during botulinum toxin A detrusor injection

Heinrich Schulte-Baukloh, Catarina Weiss, Burkert Pieske, Thorsten Schlomm, Bernhard Ralla, Hendrik Borgmann, Dirk Höppner, Sarah Weinberger

World Journal of Urology · 2025

DOI: 10.1007/s00345-025-05596-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, 2025. Verfasst von Heinrich Schulte-Baukloh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Charité- University Hospital Berlin, Berlin, Germany. heinrich.schulte-baukloh@charite.de. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Urinary Bladder, Overactive, Blood Pressure, Hypertension. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charité - Universitätsmedizin Berlin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Botulinum toxin A detrusor injection (BoNT/A-DI) is used in patients with overactive bladder (OAB) or neurogenic bladder due to multiple sclerosis (MS) or after spinal cord injury. The procedure is generally performed under local anaesthesia. We examined the influence of BoNT/A-DI on blood pressure, the most important autonomic parameter in awake patients, as a potential risk factor for cardiovascular events. Material & Methods Patients with OAB or spontaneous voiding with neurogenic detrusor overactivity (NDO) due to MS in whom BoNT/A-DI was planned under local anaesthesia, vital parameters (systolic, diastolic, and mean blood pressure; heart rate; and rate pressure product [RPP]) were recorded before, during, and after the procedure. Participants with and without previously known hypertension were compared, along with those with initial versus repeat injections, with a focus on the high-risk group, which comprised the 20% of patients with the highest baseline blood pressure values.

Results

Seventy patients were included (mean age: 64.0, median age: 66, range: 27–86 years), and two were excluded because their initial blood pressure values were too high. Sixty patients had OAB, and eight had NDO due to MS; twenty-two patients had a history of hypertension. A total of 40 patients received the first injection, and 28 received a repeat injection. Systolic blood pressure increased significantly by an average of 9.8 mmHg. However, in the hypertensive patients, systolic blood pressure rose by an average of 19.4 mmHg; isolated peak systolic values rose by up to 232 mmHg, and peak diastolic values rose by up to 128 mmHg. Cardiac stress (measured by rate pressure product [RPP]) in these patients increased significantly (RPP = 17.6 versus 7.2 in the non-hypertensive group). In the 20% of patients with the highest resting blood pressure values, systolic blood pressure rose to an average of 187.4 mmHg (15.1 mmHg compared with resting blood pressure), and cardiac workload increased by 17. No significant differences were observed between patients who received initial and repeat injections.

Conclusions

Clinicians who administer BoNT/A-DI should monitor blood pressure during the procedure and be aware of the risk of potentially significantly elevated blood pressure values during BoNT/A DI, especially in patients with a medical history of hypertension. Significantly elevated pre-interventional blood pressure values should receive an internal medicine consultation timely before the intervention to prevent cardiovascular risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type AUrinary Bladder, OveractiveBlood PressureHypertensionUrinary Bladder, NeurogenicNeuromuscular AgentsHumansMiddle AgedMaleFemaleAgedAdultAged, 80 and overInjections, Intramuscular

Stichwörter der Autor:innen

Blood pressureBotulinum toxin ACardiovascular riskDetrusor injectionNeurogenic bladderOAB

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Department of Urology, Charité- University Hospital Berlin, Berlin, Germany. heinrich.schulte-baukloh@charite.de.
  • Urologic Practice Turmstrasse, Berlin-Mitte/ Moabit, Germany. heinrich.schulte-baukloh@charite.de.
  • Department of Urology, University Hospital Brandenburg, Brandenburg, Germany. heinrich.schulte-baukloh@charite.de.
  • Urologic Practice Kurfürstendamm, Berlin-Charlottenburg, Germany.
  • Division of Cardiology, Deparmtent of Internal Medicine, University Medicine Rostock, Rostock, Germany.
  • Department of Urology, Charité- University Hospital Berlin, Berlin, Germany.

Förderung

  • Charité - Universitätsmedizin Berlin

Zitieren

APA

Schulte-Baukloh, H., Weiss, C., Pieske, B., Schlomm, T., Ralla, B., Borgmann, H., Höppner, D., & Weinberger, S. (2025). Blood pressure can be seriously elevated during botulinum toxin A detrusor injection. World Journal of Urology. https://doi.org/10.1007/s00345-025-05596-3

Vancouver

Schulte-Baukloh H, Weiss C, Pieske B, Schlomm T, Ralla B, Borgmann H, et al. Blood pressure can be seriously elevated during botulinum toxin A detrusor injection. World Journal of Urology. 2025. doi:10.1007/s00345-025-05596-3

BibTeX
@article{SchulteBaukloh2025,
  author = {Schulte-Baukloh, Heinrich and Weiss, Catarina and Pieske, Burkert and Schlomm, Thorsten and Ralla, Bernhard and Borgmann, Hendrik and Höppner, Dirk and Weinberger, Sarah},
  title = {Blood pressure can be seriously elevated during botulinum toxin A detrusor injection},
  journal = {World Journal of Urology},
  year = {2025},
  doi = {10.1007/s00345-025-05596-3}
}
Kostenlos starten →